Healthequity (NASDAQ:HQY) Issues Earnings Results, Beats Expectations By $0.33 EPS

Healthequity (NASDAQ:HQY) released its quarterly earnings data on Tuesday. The company reported $0.47 earnings per share for the quarter, beating analysts’ consensus estimates of $0.14 by $0.33, Briefing.com reports. Healthequity had a net margin of 28.13% and a return on equity of 11.77%. The company had revenue of $157.12 million during the quarter, compared to analysts’ expectations of $152.38 million. During the same quarter in the previous year, the company earned $0.25 earnings per share. The firm’s revenue for the quarter was up 122.9% on a year-over-year basis. Healthequity updated its FY 2020
After-Hours guidance to 1.46-1.52 EPS.

HQY opened at $61.24 on Wednesday. The company has a current ratio of 22.98, a quick ratio of 22.98 and a debt-to-equity ratio of 0.04. The firm’s 50-day moving average price is $59.78 and its 200 day moving average price is $64.21. Healthequity has a twelve month low of $50.29 and a twelve month high of $91.19. The firm has a market capitalization of $4.44 billion, a PE ratio of 64.46, a PEG ratio of 2.87 and a beta of 1.47.

In related news, CFO Darcy G. Mott sold 4,000 shares of Healthequity stock in a transaction that occurred on Monday, October 21st. The stock was sold at an average price of $56.90, for a total transaction of $227,600.00. Following the transaction, the chief financial officer now owns 42,000 shares in the company, valued at $2,389,800. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Insiders sold 12,000 shares of company stock valued at $715,600 over the last 90 days. Company insiders own 3.70% of the company’s stock.

Several equities analysts recently weighed in on the company. Raymond James upgraded Healthequity from an “outperform” rating to a “strong-buy” rating and cut their price target for the company from $90.00 to $80.00 in a research note on Monday, September 9th. Zacks Investment Research upgraded Healthequity from a “sell” rating to a “buy” rating and set a $62.00 price target on the stock in a research report on Tuesday, November 5th. SunTrust Banks dropped their price objective on Healthequity to $80.00 and set a “buy” rating on the stock in a report on Monday, September 9th. Bank of America set a $79.00 price objective on Healthequity and gave the company a “buy” rating in a research report on Wednesday, September 4th. Finally, ValuEngine downgraded Healthequity from a “buy” rating to a “hold” rating in a research note on Tuesday, August 6th. Three investment analysts have rated the stock with a hold rating, eleven have given a buy rating and one has given a strong buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and an average target price of $77.00.

Healthequity Company Profile

HealthEquity, Inc provides various solutions for managing health care accounts, health reimbursement arrangements, and flexible spending accounts for health plans, insurance companies, and third-party administrators in the United States. The company offers healthcare saving and spending platform, a cloud-based platform for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.

Recommended Story: What is the formula for the cash asset ratio?

Earnings History for Healthequity (NASDAQ:HQY)

Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with MarketBeat.com's FREE daily email newsletter.



Comments


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit